EC
BMEA icon

EntryPoint Capital’s Biomea Fusion BMEA Stock Holding History

EntryPoint Capital’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,444
Closed -$36.5K – 940
2024
Q1 		$36.5K Sell
2,444
-8,255
-77% -$136K 0.03% 894
2023
Q4 		$155K Buy
+10,699
New +$130K 0.15% 175

Other funds holding BMEA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EntryPoint Capital's BMEA Position: Q2 2024 in Review

EntryPoint Capital sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 2,444 shares — an estimated $36.5K sold.

EntryPoint Capital first reported a position in BMEA in Q4 2023 and held it in 2 quarters. The position peaked at $155K in Q4 2023. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

  • EntryPoint Capital reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
  • EntryPoint Capital sold 2,444 Biomea Fusion shares in Q2 2024, an estimated $36.5K.
  • EntryPoint Capital first reported a position in Biomea Fusion in Q4 2023 and held it in 2 quarters.
  • EntryPoint Capital's Biomea Fusion position peaked at $155K in Q4 2023.
  • 107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.